SAN FRANCISCO (GenomeWeb) – Early this year, Baylor Genetics launched a noninvasive prenatal 30-gene test that focuses on identifying de novo mutations that indicate autosomal dominant or X-linked disorders.
It is the first time individual genes have been analyzed in a noninvasive prenatal test in the US and it pushes the field closer to analyzing entire fetal genomes for disease risk.
Get the full story with
360Dx Premium
Only $95 for the
first 90 days*
360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try 360Dx Premium now.
Already a 360Dx Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
